Literature DB >> 21274690

The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

David F Tate1, Rola Khedraki, Daniel McCaffrey, Daniel Branson, Jeffrey Dewey.   

Abstract

In this review of the current literature, we examine the role of medical imaging in providing new and relevant information on central nervous system (CNS) injury associated with human immunodeficiency virus (HIV) infection and various clinical manifestations of this injury. Common imaging modalities used to examine CNS injury in HIV infection include structural magnetic resonance imaging, magnetic resonance spectroscopy, diffusion tensor imaging, functional MRI, and positron emissions tomography. Clinical implications for the findings are discussed for each of these modalities individually and collectively. In addition, the direction for future studies is suggested in an attempt to provide possible methods that might answer the many questions that remain to be answered on the evolution and progression of CNS injury in the context of HIV infection.

Entities:  

Mesh:

Year:  2011        PMID: 21274690      PMCID: PMC3075743          DOI: 10.1007/s13311-010-0010-4

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  125 in total

1.  Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients.

Authors:  David F Tate; Jared Conley; Robert H Paul; Kathryn Coop; Song Zhang; Wenjin Zhou; David H Laidlaw; Lynn E Taylor; Timothy Flanigan; Bradford Navia; Ronald Cohen; Karen Tashima
Journal:  Brain Imaging Behav       Date:  2010-01-19       Impact factor: 3.978

2.  Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy.

Authors:  V A Cardenas; D J Meyerhoff; C Studholme; J Kornak; J Rothlind; H Lampiris; J Neuhaus; R M Grant; L L Chao; D Truran; M W Weiner
Journal:  J Neurovirol       Date:  2009-07       Impact factor: 2.643

3.  White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study.

Authors:  N Pomara; D T Crandall; S J Choi; G Johnson; K O Lim
Journal:  Psychiatry Res       Date:  2001-02-28       Impact factor: 3.222

4.  Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy.

Authors:  A Bitsch; H Bruhn; V Vougioukas; A Stringaris; H Lassmann; J Frahm; W Brück
Journal:  AJNR Am J Neuroradiol       Date:  1999-10       Impact factor: 3.825

5.  Disease modeling in multiple sclerosis: assessment and quantification of sources of variability in brain parenchymal fraction measurements.

Authors:  Mehul P Sampat; Brian C Healy; Dominik S Meier; Elisa Dell'Oglio; Maria Liguori; Charles R G Guttmann
Journal:  Neuroimage       Date:  2010-04-01       Impact factor: 6.556

6.  HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998.

Authors:  N Sacktor; R H Lyles; R Skolasky; C Kleeberger; O A Selnes; E N Miller; J T Becker; B Cohen; J C McArthur
Journal:  Neurology       Date:  2001-01-23       Impact factor: 9.910

7.  Neural correlates of attention and working memory deficits in HIV patients.

Authors:  L Chang; O Speck; E N Miller; J Braun; J Jovicich; C Koch; L Itti; T Ernst
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

8.  Clinical and spectroscopic improvement in HIV-associated cognitive impairment.

Authors:  B Stankoff; A Tourbah; S Suarez; E Turell; J L Stievenart; C Payan; A Coutellier; S Herson; L Baril; F Bricaire; V Calvez; E A Cabanis; L Lacomblez; C Lubetzki
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

9.  Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy.

Authors:  M M Thurnher; M J Post; A Rieger; C Kleibl-Popov; C Loewe; E Schindler
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

10.  Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients.

Authors:  Ase B Andersen; Ian Law; Karen S Krabbe; Helle Bruunsgaard; Sisse R Ostrowski; Henrik Ullum; Liselotte Højgaard; Annemette Lebech; Jan Gerstoft; Andreas Kjaer
Journal:  J Neuroinflammation       Date:  2010-02-14       Impact factor: 8.322

View more
  2 in total

1.  Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.

Authors:  Elham Rahimy; Fang-Yong Li; Lars Hagberg; Dietmar Fuchs; Kevin Robertson; Dieter J Meyerhoff; Henrik Zetterberg; Richard W Price; Magnus Gisslén; Serena Spudich
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

2.  Neurological soft signs and brain morphology in people living with HIV.

Authors:  Christina J Herold; Li Kong; María Elena Ceballos; Johannes Schröder; Pablo Toro
Journal:  J Neurovirol       Date:  2022-03-29       Impact factor: 3.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.